1.52. Analysis.
Comparison 1: PDE4 inhibitor versus placebo (2020 update), Outcome 52: FEV₁ (by unknown COPD severity, roflumilast 500 µg )
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.